Pfizer, Moderna Covid shots delay response in blood cancer patients
Researchers from the Icahn School of Medicine at Mount Sinai found that almost 16 per cent of patients with multiple myeloma developed no detectable antibodies after both vaccine doses.
Researchers from the Icahn School of Medicine at Mount Sinai found that almost 16 per cent of patients with multiple myeloma developed no detectable antibodies after both vaccine doses. https://ift.tt/3dp6khd June 29, 2021 at 02:24AM
Researchers from the Icahn School of Medicine at Mount Sinai found that almost 16 per cent of patients with multiple myeloma developed no detectable antibodies after both vaccine doses. https://ift.tt/3dp6khd June 29, 2021 at 02:24AM
Comments
Post a Comment